Breaking News
Features

To your good health

Man gets diagnosed with extremely rare form of finger cancer

By Keith Roach, MD 3 min read

DEAR DR. ROACH: Do you know anything about aggressive digital papillary adenocarcinoma? My 39-year-old nephew was just diagnosed, and his parents are searching for answers. He’s getting scans to determine whether they should amputate his finger. As far as we know, it hasn’t metastasized. -- A.M.

ANSWER: No, I’d never heard of this condition. It’s extremely rare (1 in 10 million people). “Adenocarcinoma,” by definition, is cancer of the glandular tissue, and there isn’t really much glandular tissue in a finger. CANCER of any extremity is almost always of connective tissue (sarcoma). This includes cancers of the bone, muscles, fat, blood vessels or soft tissue.

Digital papillary adenocarcinoma starts in the sweat glands of the fingers or toes. It’s slow-growing and frequently misdiagnosed. Recently, it’s been discovered that these cancers are related to the human papillomavirus, specifically type 42, which is normally considered a low-risk type.

Both wide excision and amputation are effective treatments, and the five-year disease-specific survival rate is 98%. But the tumor can recur locally unless it’s very carefully removed. Metastatic disease can show up very late (up to 20 years after the tumor’s removed), so people require long-term surveillance after getting treatment.

Although this disease is very rare, there are a lot of very rare disorders (10,000 or so that are known). This means that as many as 6% of people have a rare disorder. Since they aren’t as well-known or well-understood, the diagnosis and treatment can be problematic. These conditions don’t get as much funding or recognition, so the optimal treatment isn’t always understood.

DEAR DR. ROACH: I read your recent column on gabapentin for pelvic floor dysfunction. I’ve had severe burning for over a year now, and doctors haven’t pinned it down as of today, despite many tests and scans such as MRIs. I was prescribed gabapentin for a different problem and noticed that when I use it, the burning pretty much goes away. I now use 400 mg daily, and the burning is pretty much gone. Is this a good remedy or a coincidence? -- A.A.

ANSWER: I don’t think that it’s a coincidence. Although gabapentin can have significant potential adverse effects, my experience and the medical literature support its effectiveness with pain from damaged nerves. Burning pain is a very common symptom of damaged nerves (otherwise called neuropathies). Even when the cause isn’t well-identified, gabapentin can still be effective.

A dose of 400 mg daily is very modest. It’s always possible that you’re experiencing a placebo effect (getting benefit when you take a medication that you hope will work). I think that this is less likely since you apparently didn’t take gabapentin to help your burning pain.

It’s also possible that it’s coincidental, and the pain was going away anyway when you started gabapentin. It’s very difficult to tell in any given person. However, many studies do show the effectiveness of gabapentin at helping people with burning pain that’s due to nerve damage from a wide variety of neuropathies.

Some, but by no means all, men and women with chronic pelvic pain have this condition because of a nerve injury. Gabapentin won’t help everyone with pelvic floor dysfunction.

Dr. Roach regrets that he is unable to answer individual letters, but will incorporate them in the column whenever possible. Readers may email questions to ToYourGoodHealth@med.cornell.edu.

(c) 2026 North America Syndicate Inc. All Rights Reserved

Starting at /week.